| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cell Source, Inc. | Director | Common Stock | 1,127,504 | $845,628 | $0.7500 | 30 Jun 2021 | Indirect |
| Cell Source, Inc. | Director | Director Stock Option (Right to Buy) | 300,000 | 20 Aug 2020 | Indirect | ||
| Cell Source, Inc. | Director | Series A Convertible Preferred Stock | 7,888 | 07 May 2019 | Indirect | ||
| Cell Source, Inc. | Director | Director Stock Option (Right to Buy) | 0 | 20 Aug 2020 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLCS | Cell Source, Inc. | 30 Jun 2021 | 1 | +$3,645 | 4 | Director | 07 Jul 2021, 12:55 |
| CLCS | Cell Source, Inc. | 18 May 2017 | 12 | +$120,634 | 4 | Director | 10 Jun 2021, 15:30 |